The Kleefstra Syndrome Foundation, a leading patient advocacy organization, today announced a collaboration with UT Southwestern Medical Center to advance development of a potential gene therapy to ...
Tuesday, Taysha Gene Therapies Inc (NASDAQ:TSHA) shared initial clinical data from the first pediatric patient from the REVEAL Phase 1/2 adolescent and adult trial of TSHA-102, an investigational gene ...
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for ...
"We established an international consortium with our global partners to collectively explore common potential mechanisms underlying a variety of neurodevelopmental disorders and focus on diseases with ...
Series A financing co-led by Balyasny Asset Management, venBio, and Janus Henderson InvestorsRugonersen, a potentially best-in-class antisense ...
DALLAS--(BUSINESS WIRE)--Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the ...
At Children's Hospital Colorado, Aurora, Colorado, pediatricians will soon have a new ally in diagnosing and identifying complex neurodevelopmental conditions like ...
A digital pet app used as a prescription digital therapeutic (PDT) to encourage children to complete prescribed therapies received high engagement and function scores from children living with ...
Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, is CEO of Cognoa, a leading early childhood development & pediatric behavioral health company. Neurodevelopment refers to the brain’s growth and maturation ...
Rutgers University Deploys Omni One Platform to Explore Movement-Centered XR and AI-Enhanced Behavioral Therapy Applications Collaboration Broadens Virtuix’s Applications Beyond Traditional Consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results